Development of a sustained-release formulation of inositol phosphate based inhibitors of soft-tissue calcification

• Unité de recherche: INNOSUISSE
• Numéro de projet: 38958.1 IP-LS
• Titre du projet anglais: Development of a sustained-release formulation of inositol phosphate based inhibitors of soft-tissue calcification

Description succincte (Allemand)

Development of a sustained-release formulation of inositol phosphate based inhibitors of soft-tissue calcification

Description succincte (Anglais)

Development of a sustained-release formulation of inositol phosphate based inhibitors of soft-tissue calcification

Résumé des résultats (Abstract) (Allemand)

INS-3001 is a first-in-class soft-tissue calcification inhibitor with limited oral bioavailability. This project will confirm the feasibility of devloping a novel sustained-release formulation of INS-3001, that will enable patient treatment in a chronic and ambulant setting.